Rugo HS, Loi S, Adams S, Schmid P, et al. PD-L1 Immunohistochemistry Assay Comparison in Atezolizumab plus nab-Paclitaxel-Treated Advanced Triple-Negative Breast Cancer. J Natl Cancer Inst 2021 Jun 7. pii: 6294407. doi: 10.1093.
PMID: 34097070